RecruitingNot ApplicableNCT07213154
Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
Assessment of Novel Label-free Optical Imaging Technology for the Evaluation of Skin Lesions
Sponsor
Emory University
Enrollment
10 participants
Start Date
Oct 15, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Male or Female
- Candidate with skin lesions
- Signed study-specific informed consent prior to study entry
- ≥ 18 years old
Exclusion Criteria1
- Prior surgery or radiotherapy to the area to be treated
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREQuantitative Oblique Back-Illumination Microscopy
Undergo qOBM
RADIATIONRadiation Therapy
Undergo SOC RT
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07213154
Related Trials
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
NCT066756431 location
Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors, MBRT1 Trial
NCT070620031 location
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
NCT0578671627 locations